Top Markets
Coin of the day
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.

Yumanity Therapeutics, Inc.

YMTX
Clasificación en acciones #28846
Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical... Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. Its primary focus lies in the investigation and development of therapeutic solutions for neurodegenerative conditions, particularly those driven by protein misfolding. The firm aims to discover disease-modifying treatments for a range of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration. Central to its pipeline is YTX-7739, an innovative small molecule presently in Phase I clinical trials for Parkinson's disease and associated α-synuclein disorders. Additionally, YTX-9184 is undergoing preclinical studies with the goal of treating diverse neurological conditions. The company maintains a license and research collaboration agreement with Merck Sharp & Dohme Corp. Founded in 2014, Yumanity Therapeutics Inc. is headquartered in Boston, Massachusetts.
Precio por acción
$1.89
Última sincronización: 2022-12-16
Capitalización bursátil
$24.38M
Cambio (1 día)
8.62%
Cambio (1 año)
0.00%
País
US
Comercio Yumanity Therapeutics, Inc. (YMTX)

Categoría

Historial de desdoblamientos de acciones de Yumanity Therapeutics, Inc. (YMTX)
La acción Yumanity Therapeutics, Inc. (símbolo: YMTX) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 19, 2026.
Una acción YMTX comprada antes de Aug 19, 2026 equivaldría hoy a 0 acciones YMTX.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH